Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (1448)	3/3/2000 5:53:00 PM
From: scaram(o)uche	Respond to of 2001

If they had released news today, indicating that they had licensed 2331 for a given geography (or a secondary indication), then they'd be able to put an offering on the table at a share price that would garner several years of royalties. Any number of variations on the theme would work too. Two million shares at $50/share is a lot of royalties. This company is either very quietly bent on being munched, or this is just plain miserable "window" management. Oesterling..... "more than one way to skin a cat". Glad that those of you that stuck it out are doing well. It is a highly leveraged business plan.